According to the most recent analysis by Emergen Research, the size of the global insulin delivery market reached USD 17.80 billion in 2021 and is projected to grow at a revenue CAGR of 9.9% over the forecast period. Globally rising obesity rates and the ageing population, changes in lifestyle, and adequate/established healthcare services are all factors contributing to the market's revenue...